XT
ELAB icon

XTX Topco’s Elevai Labs ELAB Stock Holding History

XTX Topco’s Portfolio ELAB Stock Details ELAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
+1,415
New +$35.8K ﹤0.01% 3935

Other funds holding ELAB

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's ELAB Position: Q2 2026 in Review

XTX Topco opened a new position in Elevai Labs (ELAB) in Q2 2026: 1,415 shares worth $17.1K. The stake represents ﹤0.01% of the portfolio and ranks #3935 among its holdings.

11 funds tracked by Wall St. Rank hold ELAB as of Q2 2026.

  • XTX Topco held 1,415 shares of Elevai Labs worth $17.1K as of Q2 2026.
  • Elevai Labs was a new XTX Topco position in Q2 2026.
  • Elevai Labs made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3935 holding.
  • 11 funds tracked by Wall St. Rank held Elevai Labs as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.